Market Overview

The percutaneous coronary intervention (PCI) devices market was valued at USD 9.50 billion in 2024 and is projected to reach USD 16.47 billion by 2034, expanding at a CAGR of 5.68% from 2025 to 2034. Demand is driven by the rising prevalence of cardiovascular diseases, increasing aging and obese populations, and favorable regulatory support. By product, the market covers coronary catheters, coronary guidewires, coronary stents, and accessories. Growth is also attributed to technological advances, new product launches, and unhealthy lifestyle habits, and millions of people globally have risk factors such as high blood pressure, smoking, and high cholesterol.

Stents Lead the Product Landscape

Coronary stents accounted for the major revenue share in 2024 owing to their high usage in heart-related procedures and ongoing technological advancements. The segment is expected to remain dominant over the study period, supported by continuous innovation from manufacturers focused on efficient clinical outcomes.

Competition is propelled by the increased use of drug-eluting stents, improved balloon technologies, and advanced catheters. In May 2024, Abbott announced the launch of its XIENCE Sierra Everolimus drug-eluting coronary stent system in India.

Regional Momentum and Procedure Volumes

North America accounted for more than 34.23% of the global market in 2024, with the US and Canada as the major revenue contributors. The growing number of Food and Drug Administration approvals and the launch of third-generation stents significantly influence the region, as newer-generation stents have shown fewer side effects and improved clinical outcomes with less chance of restenosis. According to CDC statistics cited in the report, one out of four deaths in the US is due to heart diseases, and physicians perform approximately 300,000 balloon angioplasty procedures annually. The CDC also states that someone in the US suffers a heart attack every 40 seconds.

Asia Pacific is projected to grow at the fastest rate, with Japan, India, South Korea, and China among its leading revenue generators. A high incidence of heart disease, increased procedure volumes, and contributing factors such as diabetes, obesity, and sedentary lifestyles are spurring growth. Rapid urbanization and rising disposable income have changed lifestyles in developing countries, increasing the risk of heart disease. In China, CVD causes approximately 3 million deaths every year, accounting for 41 percent of total deaths, while in the European region CVD causes more than half of the deaths.

End Use, AI, and Competitive Insight

Hospitals held the largest end-use share in 2024 owing to higher patient admissions, advanced technologies, and trained professionals. Their advanced diagnostic and therapeutic systems support accurate diagnosis and treatment, and tie-ups with reimbursement authorities such as Medicare and Medicaid increase hospital utilization. AI is also gaining relevance: it helps improve the detection of coronary blockages, guides stent selection and placement strategies, and reduces procedure time through real-time guidance.

The market shows strong competition as healthcare systems emphasize minimally invasive treatment, and companies are investing in product innovation to broaden their reach. Ongoing improvements in imaging and navigation tools further influence the landscape, which is projected to remain highly dynamic.

Browse In-depth Market Research Report:

https://www.polarismarketresearch.com/industry-analysis/percutaneous-coronary-intervention-pci-devices-market 

Key Players in the PCI Devices Market

• Abbott
• Braun
• ASAHI INTECC Company Limited
• Biosensors International Group, Ltd.
• Boston Scientific Corporation
• R. Bard
• BIOTRONIK
• Comed BV
• Cook
• Meril Lifesciences
• Cordis
• Medtronic PLC
• Merit Medical System
• Terumo Corporation

Conclusion

The percutaneous coronary intervention (PCI) devices market is moving toward USD 16.47 billion by 2034, with stent technology at the center of product development. With newer-generation designs showing fewer side effects and improved clinical outcomes, and AI supporting stent selection, suppliers that keep investing in innovation and imaging-enabled solutions will be best aligned with the evolving needs of hospitals and interventional teams.

More Trending Latest Reports By Polaris Market Research:

Meditation Management Apps Market

Trade Management Market

Surfboard Market

Neurothrombectomy Devices Market

Sleep Apnea Devices Market

Dairy Alternatives Market

Dairy Alternatives Market

Surfboard Market

Alpha-Gal Syndrome Allergy Market